15876-67-2

生物活性：Ubretid 是一种有效的血浆胆碱酯酶抑制剂。因此，Ubretid 延迟了琥珀酸的水解并延长了其作用，类似于其他抗胆碱酯酶活性分子 (如吡啶斯的明和多奈哌齐) 所显示的效果。Ubretid 具有研究尿潴留延长琥珀胆碱作用的潜力。Ubretid 通常用于研究重症肌无力和膀胱排空困难^[1]。

Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase agents, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder^[1].